Evidence map›Paper›PMID 33572388›Full record

ArticleCancers2021

Prognostic Significance of Metabolic Parameters by

Joohee Lee, Young Seok Cho, Jhingook Kim, Young Mog Shim, Kyung-Han Lee, Joon Young Choi

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. [Cancers · 2026
    Article
  2. Prognostic value as metabolic tumor activity onJournal of thoracic disease · 2026
    Article
  3. The Value of Baseline [Diagnostics (Basel, Switzerland) · 2025
    Review
  4. Machine Learning Models Derived from [Bioengineering (Basel, Switzerland) · 2025
    Article
  5. The Role of [Molecular diagnosis & therapy · 2025
    Article
  6. Article
  7. Article
  8. Diagnostic and prognostic values of 2-[European radiology · 2022
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joohee LeeDepartment of Nuclear Medicine, CHA Ilsan Medical Center, CHA University, Goyang 10414, Korea.
Young Seok ChoDepartment of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.ORCID 0000-0003-1396-4952
Jhingook KimDepartment of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Young Mog ShimDepartment of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Kyung-Han LeeDepartment of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Joon Young ChoiDepartment of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.ORCID 0000-0003-1060-0096

Funding

The National Research Foundation of Korea NRF-2020M2D9A1094072
6 · The paper itself

Abstract

backgroundImaging tumor FDG avidity could complement prognostic implication in thymic epithelial tumors. We thus investigated the prognostic value of volume-based

methodsThis is a retrospective study that included 83 patients who were diagnosed with thymic epithelial tumors and underwent pretreatment

resultsThere were 21 low-risk thymomas (25.3%), 27 high-risk thymomas (32.5%), and 35 thymic carcinomas (42.2%). Recurrence or disease progression occurred in 24 patients (28.9%). On univariate analysis, Masaoka stage (

conclusionSUV

Indexed as

18F-FluorodeoxyglucosePET/CTprognosisstandardized uptake valuethymic epithelial tumor

Identifiers

PMID33572388
PMCPMC7916204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.